CRISPR–Cas12-based detection of SARS-CoV-2
James P. Broughton(Mammoth Biosciences (United States)), Charles Y. Chiu(University of California, San Francisco), Wei Gu(University of California, San Francisco), Alicia Sotomayor-González(University of California, San Francisco), Chao‐Yang Pan(California Department of Public Health), Guixia Yu(University of California, San Francisco), Elaine Hsu(University of California, San Francisco), Andrea Granados(University of California, San Francisco), Jessica Streithorst(University of California, San Francisco), Allan Gopez(University of California, San Francisco), Steve Miller(University of California, San Francisco), Debra A. Wadford(Centers for Disease Control and Prevention), Hugo Guevara(California Department of Public Health), Venice Servellita(University of California, San Francisco), Xin Miao(Mammoth Biosciences (United States)), Xianding Deng(University of California, San Francisco), Jasmeet Singh(Mammoth Biosciences (United States)), Kelsey C. Zorn(University of California, San Francisco), Clare L. Fasching(Mammoth Biosciences (United States)), Janice S. Chen(Mammoth Biosciences (United States))
Cited by 2,809
Related Papers
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
|Science|2018|4.4k
Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans
|Science|2009|2.5k
Programmed DNA destruction by miniature CRISPR-Cas14 enzymes
|Science|2018|1.2k
Enhanced proofreading governs CRISPR–Cas9 targeting accuracy
|Nature|2017|1.2k
Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing
|New England Journal of Medicine|2014|1k